Pulmonary Arterial Hypertension market research Archives | DelveInsight Business Research

Tag: Pulmonary Arterial Hypertension market research

Recent Pharma News

Notizia

May 21, 2019• DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Notizia

Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension Therapies

May 17, 2019• Articles, Business Consultant, DelveInsight's Drug Report, Pharma Consultant

Pulmonary Arterial Hypertension (PAH) is a chronic, life-alarming disease that advances over time. It is a rare disease characterized by...

Thyroid awareness month

Infographics
Acceleron Pharma’s drug sotatercept touches the phase 2 mark; GT Medical receives nod for GammaTile; New treatment strategy for Parkinson’s disease

Business Consultant, Pharma Consultant, Pharma news
Announcement of the new logo: Introducing a new brand identity, and a new website.

Business Consultant, Pharma Consultant
Thyroid eye disease market: New therapies enter the TED market

Articles, Business Consultant, Pharma Consultant
Tepezza receives approval; a new way to treat Alzheimer’s; and a new anti-obesity molecule

Business Consultant, Pharma Consultant, Pharma news
Polypills: Can they offer a potential approach to treat CVDs?

Business Consultant, Pharma Consultant, Snippets
Imfinzi combo gets ODD; Mayzent gets EU nod; Positive results of VP-102

Business Consultant, News, Pharma Consultant
In a blind race to cure HIV, can Gene therapy be a deal-breaker?

Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant
Glaucoma therapeutics market: Present therapies and unmet needs

Articles, Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Pharma Consultant
Thumbs down to NKTR-181, Lilly expands its insulin armamentarium, 23andMe out-licences its drug

Business Consultant, Pharma Consultant, Pharma news